Response to ‘Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp’

J. Malvehy, S. Puig
  • British Journal of Dermatology, February 2018, Wiley
  • DOI: 10.1111/bjd.16216

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/bjd.16216

The following have contributed to this page: Susana Puig

In partnership with: